반응식
[N+:1]([C:4]1[CH:13]=[CH:12][CH:11]=[C:10]2[C:5]=1[CH:6]=[CH:7][C:8](Cl)=[N:9]2)([O-])=O.[CH3:15][C:16]1[O:20][C:19]([CH2:21][NH2:22])=[CH:18][CH:17]=1.[NH:23]1[C:27]2[CH:28]=[CH:29][C:30]([CH:32]=O)=[CH:31][C:26]=2[N:25]=[CH:24]1>>[NH:23]1[C:27]2[CH:28]=[CH:29][C:30]([CH2:32][NH:1][C:4]3[C:5]4[CH:6]=[CH:7][C:8]([NH:22][CH2:21][C:19]5[O:20][C:16]([CH3:15])=[CH:17][CH:18]=5)=[N:9][C:10]=4[CH:11]=[CH:12][CH:13]=3)=[CH:31][C:26]=2[N:25]=[CH:24]1참가 물질
4
실험 절차
The title compound, MS: m/e=384.1 (M+H+), was prepared from 5-nitro-2-chloroquinoline, 5-methyl-2-furanmethanamine and 1H-benzimidazole-5-carbaldehyde as described in example 26.
출처 및 근거
- ORD 기록
- ord-ce3f18d5de2340cf986ed91da7b097b9
- 출처 데이터셋
- uspto-grants-2010_11
- 특허 번호
- US07825253B2
연결된 노트
불러오는 중…